These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 23178231)

  • 21. New gene targets related to schizophrenia and other psychiatric disorders: enzymes, binding proteins and transport proteins involved in phospholipid and fatty acid metabolism.
    Horrobin DF; Bennett CN
    Prostaglandins Leukot Essent Fatty Acids; 1999 Mar; 60(3):141-67. PubMed ID: 10359017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Lithium in psychiatry].
    Schou M
    Encephale; 1971; 60(4):281-311. PubMed ID: 5004892
    [No Abstract]   [Full Text] [Related]  

  • 23. Psychiatric Disorders and Polyphenols: Can They Be Helpful in Therapy?
    Trebatická J; Ďuračková Z
    Oxid Med Cell Longev; 2015; 2015():248529. PubMed ID: 26180581
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Opiates, opioid peptides and psychiatry.
    Davis GC; Buchsbaum MS; Bunney WE
    Ann N Y Acad Sci; 1981; 362():67-75. PubMed ID: 7020533
    [No Abstract]   [Full Text] [Related]  

  • 25. Alterations in the expression of PSA-NCAM and synaptic proteins in the dorsolateral prefrontal cortex of psychiatric disorder patients.
    Gilabert-Juan J; Varea E; Guirado R; Blasco-Ibáñez JM; Crespo C; Nácher J
    Neurosci Lett; 2012 Nov; 530(1):97-102. PubMed ID: 23022470
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Changes in brain-derived neurotrophic factor following treatment with mifepristone in bipolar disorder and schizophrenia.
    Mackin P; Gallagher P; Watson S; Young AH; Ferrier IN
    Aust N Z J Psychiatry; 2007 Apr; 41(4):321-6. PubMed ID: 17464718
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of hippocampal brain-derived neurotrophic factor and its receptors in Stanley consortium brains.
    Dunham JS; Deakin JF; Miyajima F; Payton A; Toro CT
    J Psychiatr Res; 2009 Sep; 43(14):1175-84. PubMed ID: 19376528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of carbamazepine in psychiatric disorders.
    Birkhimer LJ; Curtis JL; Jann MW
    Clin Pharm; 1985; 4(4):425-34. PubMed ID: 2864160
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The therapeutic potential for tryptophan and melatonin: possible roles in depression, sleep, Alzheimer's disease and abnormal aging.
    Maurizi CP
    Med Hypotheses; 1990 Mar; 31(3):233-42. PubMed ID: 2345536
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Medication effects on one-carbon metabolism in schizophrenia, mania, and major depression.
    Morere DA; Alarcon RD; Monti JA; Walter-Ryan WG; Bancroft AJ; Smythies JR; Tolbert LC
    J Clin Psychopharmacol; 1986 Jun; 6(3):155-61. PubMed ID: 2872235
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The structural neuroimaging of bipolar disorder.
    Emsell L; McDonald C
    Int Rev Psychiatry; 2009; 21(4):297-313. PubMed ID: 20374145
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lithium augmentation in treatment-resistant depression: clinical evidence, serotonergic and endocrine mechanisms.
    Bschor T; Lewitzka U; Sasse J; Adli M; Köberle U; Bauer M
    Pharmacopsychiatry; 2003 Nov; 36 Suppl 3():S230-4. PubMed ID: 14677084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Influence of personality factors on the success of psychopharmacotherapy].
    Rüger U
    Psychiatr Prax; 1985 Jan; 12(1):5-7. PubMed ID: 2858900
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Subjective life satisfaction and objective functional outcome in bipolar and unipolar mood disorders: a longitudinal analysis.
    Goldberg JF; Harrow M
    J Affect Disord; 2005 Dec; 89(1-3):79-89. PubMed ID: 16249035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Valproate and neuroprotective effects for bipolar disorder.
    Atmaca M
    Int Rev Psychiatry; 2009; 21(4):410-3. PubMed ID: 20374154
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Drugs for psychiatric disorders.
    Med Lett Drugs Ther; 1983 May; 25(635):45-52. PubMed ID: 6843486
    [No Abstract]   [Full Text] [Related]  

  • 37. Mitochondrial detachment of hexokinase 1 in mood and psychotic disorders: implications for brain energy metabolism and neurotrophic signaling.
    Regenold WT; Pratt M; Nekkalapu S; Shapiro PS; Kristian T; Fiskum G
    J Psychiatr Res; 2012 Jan; 46(1):95-104. PubMed ID: 22018957
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Psychiatric vulnerability: suggestions from animal models and role of neurotrophins.
    Alleva E; Francia N
    Neurosci Biobehav Rev; 2009 Apr; 33(4):525-36. PubMed ID: 18824030
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Drugs for psychiatric disorders.
    Med Lett Drugs Ther; 1991 May; 33(844):43-50. PubMed ID: 1674103
    [No Abstract]   [Full Text] [Related]  

  • 40. A prospective comparative study of interaction between lithium and modified electroconvulsive therapy.
    Thirthalli J; Harish T; Gangadhar BN
    World J Biol Psychiatry; 2011 Mar; 12(2):149-55. PubMed ID: 20645670
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.